March 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


BCRP and OCRP Pre-Announcement for 2017

NEW
To be Announced See Links Below Federal Breast/Ovarian

CDMRP
Breast Cancer Research Program (BCRP) &
Ovarian Cancer Research Program (OCRP)
FY17 Pre-announcements

Descriptions of the initiatives planned for these programs can be found at the links below.  The pre-announcements allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Contact: Office of Sponsored Research (x6804)
Program Links: Breast Cancer Research Program  
Ovarian Cancer Research Program


Reminder
Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Letters of intent are accepted year round; full applications are by invitation only.
Amount & Project Period: Gateway funds research studies with a budget estimate in the range of $200,000-$800,000.  1 - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Application Process

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1


February 20 (LOI) Junior Faculty Non-federal Career Development

Lungevity Foundation
2017 Career Development Awards for Translational Research

Projects that will be funded in 2017 are expected to have a direct impact on early detection of lung cancer or on outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.
Due Dates: Feb. 20 (Letter of Intent) 9:00pm EST
Invited Applications:  May 03 (OSR) Ι May 05 (Sponsor)
Note:  LUNGevity will grant only one Career Development Award per institution
Amount & Project Period: $300,000 - 3 years
Eligibility: Must be w/in first 5 years of faculty appointment;
May not have a major award, such as an RO1, DOD, or Merit review, or a Career Development Award, such as a K07, K08, or K23;
Must be U.S. citizen or foreign national holding one of the following visa immigration statuses: permanent resident (Green Card), exchange visitor (J-1), temporary worker in a specialty occupation (H-1, H-1B), Canadian or Mexican citizen engaging in professional activities (TC or TN), or temporary worker  with extraordinary abilities in the sciences (O-1). 
Contact: Office of Sponsored Research (x6804)
Links: Guidelines | proposalCENTRAL (Submission Site)





February 20 Postdocs Non-federal Career Development

Society for Immunotherapy of Cancer (SITC)
2017 SITC Fellowship Awards

Supports development of young investigators in translational cancer immunotherapy to cultivate the next generation of cancer immunotherapy experts with a vested interest in furthering the clinical research of immunotherapy in lung cancer.
Due Dates: Feb. 16 (OSR) Ι Feb. 20  (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: Must be current SITC member;
Must hold an MD, PhD or combined MD/PhD degree;
Must currently hold position of postdoc, resident, research scientist or comparable position;
Must be w/in postdoc or postgraduate training, or <4 years from completing training;
Must commit 75% effort to research supported by fellowship
Contact: Office of Sponsored Research (x6804)
Link: Current Opportunities

NEW

Restricted submission - pre-application required
February 22 Tenure Track faculty Non-federal Translational

V Foundation
2017 Cancer Research Grant Program
Translational Award - Restricted Submission

A funding opportunity for translational research projects for pre-clinical and clinical investigators. Projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. One application is allowed, but Moffitt may submit two if one is a research project focusing on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations.
Due Dates: Feb. 22  to:
 Maureen.ahearn@moffitt.org (must incl.1-page letter of   introduction and 2-page outline; must be submitted electronically in   PDF format)
Eligibility: Research team leaders must: be scientists w/a tenure-track   faculty position.
Contact: Maureen.ahearn@moffitt.org (x8824) for inquiries
Link: V-Foundation RFP


February 22 - Noon, EST All Faculty Ranks Non-federal Pancreatic

Pancreatic Cancer Action Network (PANCAN)
Precision Medicine Targeted Grant

This Request for Applications is to solicit Precision Medicine Targeted Grant applications to provide funding for projects that can be incorporated directly into Precision Promise sub-studies at the end of the current funding period.
Due Dates: Feb. 20 (OSR) Ι Feb. 22 - Noon, EST (Sponsor)
Amount & Project Period: Up to $1,000,000 (Total) - 2 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: Apply Now Ι Guidelines and Application Instructions
proposalCENTRAL

NEW
February 22, 3:00pm, EST (LOI) All Ranks Non-federal HIV

American Federation for Aids Research
Innovation Grants: Exploring the Potential for HIV Eradication

To fund biomedical research necessary to inform and design interventions to 1) cure HIV, defined by the eradication of all pathogenic virus from the body, or 2) bring about a state of remission whereby the virus is controlled in the absence of ART and the person is no longer infectious.   Specific areas of interest in order of priority: 1. Proof-of-concept clinical studies testing cure interventions 2. Disabling or eradicating the HIV reservoir 3. Discovery and targeting of novel mechanisms to disrupt HIV reservoir persistence
Due Dates: Feb. 22, 3:00pm EST (Letter of Intent) Must register by 3:00 pm EST Feb. 16th.  CLICK HERE to register.
Invited  Applications: Apr. 28 (OSR) May 02 (Sponsor)
Amount & Project Period: $200,000 (TOTAL) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: RFP Overview
R01 NIH

February 23 New Investigators Federal Tobacco Regulatory Science

Tobacco Regulatory Science Small Grant Program for New Investigators

The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.  Applicants are encouraged to conduct projects that ultimately have potential to inform regulations on tobacco product manufacturing, distribution, and marketing.
Due Dates: Feb. 21 (OSR) Ι Feb. 23 (Sponsor) Final due date for this RFA
Amount & Project Period: Budgets limited to $75,000/yr. (Direct Costs) - 2 years
Eligibility: Only New Investigators are eligible.  FOA excludes individuals who have received the following from any NIH Institute or Center:
   Pathway to Independence Award-Research Phase (R00)
   Small Grant (R03) support in Tobacco Regulatory Science
   Exploratory/Developmental Grant (R21) in Tobacco  
   Regulatory Science
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-15-004



February 27 All Ranks Moffitt See Below

Moffitt Innovative Studies Funding Opportunity - FORMA Therapeutics, Inc.

Moffitt Cancer Center invites Moffitt investigators (all ranks) to apply for funds for a grant within the broad areas of epigenetics, protein homeostasis, metabolism, immune oncology, and novel therapeutic targets.
Due Dates: Feb. 27 (OSR) Proposals must be submitted to OSR and OSR will forward by Mar. 01 to Alliance Management
Amount & Project Period: $100,000 (Direct Costs) - 12 months
Eligibility: All Ranks
Contact: Rae Reuille (x1548) or Alliance Management
Links: Guidelines  Ι  Application

February 28 All Faculty Ranks Non-federal Myelodysplastic Syndrome (MDS)

Aplastic Anemia and MDS International Foundation (AAMDISF)
Research Grants

Topic areas considered for funding include:
1.    Promoting understanding of the etiology and pathogenesis of aplastic anemia, MDS or PNH;
2.    Improving symptom management and the quality of life for aplastic anemia, MDS or PNH
       patients;
3.    Discovering new treatments for aplastic anemia, MDS or PNH;
4.    Understanding and preventing complications of bone marrow failure conditions (e.g., blood clotting/thrombosis in PNH, iron overload in MDS, etc.); and,
5.    Research regarding inherited bone marrow failure disorders, provided a strong case is also made for pertinence of the research to acquired disorders.
Due Dates: Feb 24 (OSR) Ι Feb. 28 (Sponsor)
Amount & Project Period: Up to $60,000 - 2 years
Eligibility: New & established Investigators - New Investigators are post-doctoral fellows, instructors and those who have been asst. professors for <5 years.  Established Investigators have been asst. professors for >5 years or are associate or full professors
Contact: Office of Sponsored Research (x6804)
Links: Fund Your Research Ι proposalCENTRAL (Submission Site)

NEW
March 01 Postdocs/Junior Faculty Non-federal Career Development

Bladder Cancer Advocacy Network (BCAN)
Young investigator Award

This award is for researchers in basic, translational, clinical, epidemiologic, bio-engineering or any other scientific or research field, who are working in a research environment capable of supporting transformational bladder cancer research. 
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Must be w/in 6 years of completing a professional degree such as MD, PhD, MD-PhD, MPH, or equiv. or clinical training such as residency or fellowship.
Applicant may hold title of Senior Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor or equiv. At the start of the grant, applicant cannot hold title of Associate Professor.
Proof of permanent resident status or a valid a work visa is required if not an American or Canadian citizen.
Contact: Office of Sponsored Research (x6804)
Links: Young Investigator Award Ι Application Guidelines
proposalCENTRAL


NEW
March 01 See Below Non-federal Career Development/Melanoma

Melanoma Research Foundation
2017 Request for Proposals

Due Dates: Feb. 27 (OSR) | Mar. 01 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Links: MRF's 2017 Request for Proposals Ι ProposalCENTRAL
 

Established Investigator Awards (EIA)

For established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. Use of relevant genetic models and human derived tumor samples is highly encouraged.  EIA applications are encouraged, but not required, to be part of the STP mechanism listed below.
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Must have a title equivalent to Assoc. Professor or higher, Tenure and Non-tenure Tracks.
 

Specific Topic Proposals

The following categories are the identified unmet needs in melanoma research selected as STPs for 2015 (See RFA for details):
1.  Prevention: Development of models and biomarkers
Identifying mechanisms and respective therapeutic strategies in less common molecular subsets of melanoma
2.  Metastases: Dormancy and metastatic progression
3.  CNS Metastases: Development of markers of risk and rational therapeutic approaches      4.  Response to Treatment: Mechanisms and respective biomarkers for predicting response and for monitoring therapeutic response
5.  Resistance: Intrinsic/Innate/Primary resistance to immunotherapies in melanoma
Eligibility: All Ranks - See RFP
 

Career Development Awards (CDA)

For investigators beginning a research career focused on melanoma who have not yet established strong federal funding for their research. The use of relevant genetic models and human derived tumor samples is highly encouraged. CDA applications are encouraged, but not required, to be part of the STP mechanism listed below.
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Postdocs must have <5 years postdoctoral experience at time of grant award and must not have previously received any major grant support.
May have title of Research Associate/ Scientist, Instructor, Assistant Professor, or equiv., and individuals in this category may have previous grant support (e.g. K08, K99, etc.).
R01 NCI

March 01 All Ranks Federal Cancer Imaging

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Additional 2017 Due Dates:  June 7th & October 3rd
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-093
Admin. Supplement NIH
NCI is a participating Institute
March 01 See Below Federal SGM Populations

Administrative Supplements for Research on Sexual and Gender Minority (SGM) Populations

This effort is intended to encourage investigation in an underrepresented, but growing, field of research. To increase collective understanding of the broad range of the health needs of SGM populations, the supplement will focus on areas of specific research interest, including, but not limited to: studies on increased disease risk; mental, behavioral and social health; approaches to personalized medicine; access to care; reproductive and sexual development; neurological and cognitive development; and resilience.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: Must not exceed $100,000 (total costs) - 1 year (Must be w/in currently approved project period of parent award.)
Eligibility: Individual(s) must hold an active grant or cooperative agreement, and research proposed in supplement must be accomplished w/in competitive segment of active award.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-098


NEW
March 01 Established Female Investigators Non-federal Women in Biological Science

Federation of American Societies for Experimental Biology
2018 Excellence in Science Award
 "Recognizing the Research Accomplishments of Women Scientists"

This award is given in recognition of outstanding achievement by women in biological science.  Recipients are women whose career achievements have contributed significantly to further our understanding of a particular discipline by excellence in research.
Due Dates: Mar.  01
Amount & Project Period: $10,000 unrestricted research grant
Eligibility: Nominators and nominees: must be a member of at least one FASEB Member Society but do not have to be members of the same society.
Award recipient will be expected to present an Excellence in Science Award Lecture at the annual meeting of a FASEB Member Society
Contact: Office of Sponsored Research (x6804)
Link: Overview




March 01 Postdocs/Junior Faculty Non-federal Clinical Oncology/Fellowship

Dr. Charles A. Coltman, Jr., Fellowship Program

To pursue mentored clinical research initiatives.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Any oncology fellow in training OR
Junior faculty in the first 5 years of appointment at a member or affiliated SWOG Institution at application submission.
Contact: Office of Sponsored Research (x6804)
Link: Research & Funding



March 01 Postdocs Non-federal Career Development

Bonnie J Addario Lung Cancer Foundation (ALCF) and International Association for the Study of Lung Cancer (IASLC)
2017 ALCF-IASLC Joint Fellowship Award

The purpose is to support novel, innovative and translational research with potential of high clinical impact on the early detection of lung cancer.
Due Dates: Feb 27 (OSR) Ι Mar. 01, Receipt Date (Sponsor)
Amount & Project Period: $300,000 - 2 years
Eligibility: Applicants (MD/PhD/ MD, PhD) must be w/in 5 years of first faculty appointment as of June 5, 2015.
Applicants who have completed 2 years of fellowship/post-doctoral training and are on track for faculty appointments are eligible.
Documentation of an equal in-kind level of support (in the form of dedicated space, equipment, institutional overhead, core institutional resources, etc.) is required in a letter of support from the Cancer Center Director or Departmental Chairperson 
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


March 01 All Faculty Ranks Non-federal Leukemia

WES Leukemia Research Foundation
2017 Request for Proposals in Leukemia Research

Provides support for laboratory, translational, or clinical research related to acute leukemia.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor (Receipt Date))
Amount & Project Period: $50,000 - 1 year
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


March 01 Junior Faculty Non-federal Career Development

American Association for the Advancement of Science (AAAS)
Martin and Rose Wachtel Cancer Research Award

This award honors early-career investigators who have performed outstanding work in the field of cancer research.  As part of the application package, entrant will submit an essay describing his or her research project and explaining how it advances our understanding of cancer.  Award winner(s) are invited to deliver a public lecture on their research.
Due Dates: Feb. 27 (OSR) Ι Mar. 01 (Sponsor)
Amount & Project Period: $25,000 cash award
Eligibility: Must have received Ph.D. or M.D. w/in last 10 years.
Research must have been performed during previous 10 years.
Applicant must have performed or personally directed work described in Essay.
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidelines








NEW
March 08 (LOI) See Below Non-federal Lung

SU2C-LUNGevity-American Lung Association Lung Cancer Interception Dream Team

This initiative represents a new, focused effort to implement advances in cancer interception and prevention research as rapidly as possible through the creation of a collaborative, translational, cancer research "Dream Team." The most talented and promising researchers across institutions will be assembled into a Dream Team, forming an optimal configuration of expertise needed to solve key problems in lung cancer interception and prevention research.
Due Dates: Mar. 08 (Letter of Intent)
Invited Submissions:  May 10 (OSR) May 12 (Sponsor)
Amount & Project Period: $7M - 4 years All funding is contingent upon milestones and objectives being appropriately selected and satisfactorily pursued and achieved.
Eligibility: Must include laboratory and clinical researchers, senior and young investigators, and senior scientists who have not necessarily worked together in the past;
Each Team will consist of a Dream Team Leader, a Dream Team Co-leader, no more than 4 addnl. Dream Team Principals, and at least 2 Advocates, w/a minimum of 3 participating institutions See Dream Team Eligibility Criteria in Guidelines for additional requirements.
Contact: Office of Sponsored Research (x6804)
Link: proposalCentral (RFA located at this site which is also   submission site.)

March 13 Junior Faculty Non-federal Career Development

The Prostate Cancer Foundation (PCF)
2017 PCF Young Investigator Awards

Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. "Small-step" or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to "bench to bedside" translational research proposals with the potential to deliver near term benefit to patients.
Due Dates: Mar. 09 (OSR) Ι Mar. 13, 3:00pm ET (Sponsor)
Amount & Project Period: $225,000/yr. - 3 years
Eligibility: Applicant sh/be w/in 6-years of completing a professional degree or clinical training, and must hold title of Postdoctoral Fellow, Instructor, Research Assoc., Asst. Professor or equiv;
Applicant should have received no more than $200,000 in current direct research funding from all sources including institutional funds;
Must be under direct supervision of a mentor
Contact: Office of Sponsored Research (x6804)
Links: RFA Ι Young Investigator Awards


NEW
March 14 (Concept paper) Postdocs Non-federal Career Development

Thrasher Research Fund
Early Career Awards

The purpose of this program is to encourage the development of medical research in child health.
Due Dates: Mar. 14, Noon MST (Concept Paper)
Invited  Applications: Apr. 26 (OSR) Apr. 28 (Sponsor)
2017 Fall Cycle:  Sept. 19th, Noon MST (Concept Paper)
Amount & Project Period: $25,000 - Up to 2 years
Eligibility: Physicians who are in (or have completed no more than 1 year before submission of Concept Paper) a residency/fellowship training program;
Post-doctoral investigators w/degree completion no more than three years before submission of Concept Paper;
No restrictions w/regard to citizenship.
Contact: Office of Sponsored Research (x6804)
Link: Early Career Awards
Admin. Supplement NLM
NCI is a participating Institute
March 15 See Below Federal Digital Research Data

NLM Administrative Supplements for Informationist Services in NIH-funded Research Projects

These administrative supplements provide funds to active awards of participating Institutes and Centers in order to enhance the storage, organization, management and use of digital research data through the involvement of informationists, also known as in-context information specialists.
Due Dates: Mar. 13 (OSR) Ι Mar. 15 (Sponsor)
Amount & Project Period: May not exceed $25,000/year (Direct Costs)
Project and budget periods must be w/in currently approved project period for the existing parent award and must be no more than 3 years.
Eligibility: Must hold an active grant or cooperative agreement, and research proposed in supplement must be accomplished w/in competitive segment of active award.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-090


March 15 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award

This program accepts project proposals for all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Due Dates: Mar 13 (OSR) Ι Mar. 15 (Receipt - (Sponsor))
(Application hard copy and USB flash drive required)
Amount & Project Period: $208,000 - Level 1 (PhD) - 4 years
$248,000 - Level 2 (US board cert. MD/PhD) - 4 years
Eligibility: This cycle is for those with degrees conferred between April 15, 2016 and March 15, 2017 and who joined sponsor's  lab on or after April 15, 2016.
Contact: Office of Sponsored Research (x6804)
Link: Award Overview


March 15 Junior Faculty Non-federal Career Development

The Sontag Foundation
The Distinguished Scientist Award (DSA)

This award will fund projects that show potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer.
Due Dates: Mar. 13 (OSR) Ι Mar. 15 (Noon - Sponsor(Receipt))
Amount & Project Period: $600,000 - 4 years
Eligibility: At time of application, applicants must hold first independent, tenure-track, full-time faculty appointment at assistant professor, independent researcher or equiv. level.
Contact: Office of Sponsored Research (x6804)
Link: Overview and Guidelines


NEW
March 16 All Ranks Non-federal Metabolomics

Southeast Center for Integrated Metabolomics
2017 Pilot & Feasibility Project Awards

The purpose of the Pilot and Feasibility Program is to enhance metabolomics research by providing support for investigators new to the metabolomics field, the development of new teams and partnerships, and high-risk/high-impact research. The Pilot and Feasibility Program aims to form new multidisciplinary collaborations that will enhance the integration of new techniques that benefit multiple investigators. Applications from basic, translational, and clinical researchers are welcomed.
Due Dates: Mar. 14 (OSR) Ι Mar. 16 (Sponsor)
Additional 2017 Due Date:  Oct. 01
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks - Young investigators and investigators who are new to the field of metabolomics are especially encouraged to apply.
Contact: Office of Sponsored Research (x6804)
Link: RFA: 2017 Pilot and Feasibility Projects
U24 NCI

NEW
March 17 All Ranks Federal Immunology

Cancer Immunologic Data Commons (CIDC)

The purpose is to solicit applications for establishment of a Cancer Immunologic Data Commons (CIDC) to provide bioinformatics support as part of a Network for correlative studies in clinical trials involving cancer immunotherapy.
Due Dates: Mar. 15 (OSR) Ι Mar. 17 (Sponsor) - Note:  updated due date
Amount & Project Period: Not to exceed $650,000/yr. (Direct Costs) -  5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-006
Companion RFA: RFA-CA-17-005, U24 Resource-Related Research Projects - Cooperative Agreements
U54 NCI

March 20 LOI All Faculty Federal Cancer Systems Biology

Research Centers for Cancer Systems Biology Consortium

This RFA invites applications for Research Centers that utilize systems biology approaches to build predictive models of cancer initiation, progression and metastasis. Cancer Systems Biology Consortium (CSBC) Research Centers will consist of interdisciplinary teams of scientists (e.g., engineers, chemists, computer scientists, mathematicians, physicists) and cancer researchers (e.g., cancer biologists, oncologists, pathologists) who collaborate to advance the understanding of cancer biology and oncology.
Due Dates: Mar. 20 (Letter of Intent)
Applications:  Apr. 18 (OSR) Ι Apr. 20 (Sponsor)
Note:  Pre-application webinar January 26 at 2:00pm
            (NOT-CA-17-011)
Amount & Project Period: May not exceed $1.5M/yr. (Direct Costs) - 5 years
Eligibility: All Faculty
Multi-PD/PI mechanism encouraged;
PD/PI (or contact PD/PI on proposals w/multiple PD(s)/PI(s)) must be a scientist w/formal training and/or expertise in cancer systems biology;
Leadership team must also include an additional PD(s)/PI(s) or other senior investigator w/appropriate primary expertise and substantial contributions in the field of cancer research.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-15-014
Companion FOA/RFA: PAR-16-131 (U01) Emerging Questions in Cancer Systems Biology
RFA-CA-15-015 (U24) Coordinating Center for the Cancer Systems Biology Consortium and the Physical Sciences-Oncology Network






NEW
March 22 (LOI) See Below Non-federal Pancreatic

SU2C-Lustgarten Foundation Pancreatic Cancer Interception Dream Team

 Prioritized areas of interest include both applied and fundamental research including: discovery and implementation of innovative methods that effectively detect pancreatic cancer at an early and surgically curable stage; new tools for monitoring disease progression and therapeutic response, which could potentially serve as surrogate endpoints for clinical trials and regulatory approval; investigation of novel chemoprevention or immune prevention approaches; development of risk prognostication methods for pre-invasive pancreatic neoplasms and other conditions that elucidate molecular details underlying that increased risk; understanding of immune suppression and inflammation mechanisms that promote pancreatic cancer and design of methods to circumvent this; and more generally research targeted at generating sufficient knowledge to justify a clinical intervention to test novel hypotheses related to early detection and treatment of pancreatic cancer.
Due Dates: Mar. 22 (Letter of Intent)
Invited Submissions:  June 22 (OSR) June 26 (Sponsor)
Amount & Project Period: $7M - 4 years (All funding is contingent upon milestones and objectives being appropriately selected and satisfactorily pursued and achieved.)
Eligibility: Must include laboratory and clinical researchers, senior and young investigators, and senior scientists who have not necessarily worked together in the past;
Each Team will consist of a Dream Team Leader, a Dream Team Co-leader, no more than 4 addnl. Dream Team Principals, and at least 2 Advocates, w/a minimum of 3 participating institutions See Dream Team Eligibility Criteria in Guidelines for additional requirements.
Contact: Office of Sponsored Research (x6804)
Link: proposalCentral (RFA located at this site which is also   submission site.)
Admin. Supplement NIH
NCI is a participating Institute
March 30 See Below Federal Career Development

Research Supplements to Promote Diversity in Health-Related Research

The supplements to promote diversity will provide funding to recruit and support students, postdocs, and eligible investigators from groups that have been shown to be underrepresented in health-related research.
Due Dates: NCI accepts applications through March 30th.  Submissions are to be made to OSR no later than 48 hours prior to the planned submission date. 
Applications will be accepted for a second round from October 1 - December 1, 2017.
Amount & Project Period: Varies with level of candidate;
Salary support and addnl. funds for supplies & travel vary depending on level of candidate.
Eligibility: Parent grant must have at least 2 years support remaining;
An R01 or R01-equivalent grant may support no more than 2 Diversity Supplement candidates;
An R21 or R21-equivalent grant may support no more than 1 Diversity Supplement candidate whose career level is graduate student or more junior;
Must be citizens or non-citizen nationals of the U.S. or have been lawfully admitted for permanent residence in the U.S.
Graduate student and postdocs receiving support from an agency of the Public Health Service (PHS) at time of submission are not eligible
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-288 (Research Supplements to Promote Diversity in Health-Related Research)
NCI Diversity Supplement Guidelines
Admin. Supplement NIH
NCI is a participating Institute
March 30 See Below Federal Career Development

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers  

 The purpose of the supplement is to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances. Provides supplemental funds to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals to update their existing research skills and knowledge.
Due Dates: NCI accepts applications through March 30th.  Submissions are to be made to OSR no later than 48 hours prior to the planned submission date. 
Applications will be accepted for a second round from October 1 - December 1, 2017.
Amount & Project Period: Postdoctoral fellows:  salary not to exceed $50,000/yr. Supplies/travel: up to $6,000/yr. w/justification.
Investigators developing independent research careers: salary consistent w/institutional policy and w/level of support provided by an NCI CDA, but not to exceed $100,000/yr. Supplies and travel: up to $10,000/yr., w/justification.
Eligibility: Parent grant must have at least 2 years support remaining;
See NCI Guidelines for candidate eligibility requirements
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-16-289
NCI Re-Entry Supplements Guidelines (Please note that the guidelines still has the old Program Announcement link, but that is to be updated.)




NEW
March 31 All Ranks Federal Health Equity

Department of Health & Human Services
Office of Minority Health
Partnerships to Achieve Health Equity

The purpose of the Partnership program is to demonstrate that multi-partner collaborations that address social determinants of health and have a nationwide or regional reach, focus or impact can efficiently and effectively do one of the following: (1) improve access to and utilization of care by racial and ethnic minority and/or disadvantaged populations; (2) develop innovative models for managing multiple chronic conditions; (3) increase the diversity of the health workforce; or (4) increase data availability and utilization of data that increases the knowledge base regarding health disparities and facilitates the development, implementation and assessment of health equity activities.
Due Dates: Mar 29 (OSR) | Mar. 31 (Sponsor)
Technical Assistance Webinar:  February 22, 2017 at 3:00-4:00 pm ET - Register 
Additional Technical Assistance Webinar: "Evaluation - Review the Basics":  February 23, 2017 at 3:00-4:30 pm ET - Register  
Amount & Project Period: $325,000-$400,000/yr. - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link:  MP-CPI-17-001


NEW
March 31 See below Non-federal Career Development

American Society for Radiation Oncology

Due Dates: Mar. 29 (OSR) Ι Mar. 31 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: proposalCENTRAL
 

2017 Junior Faculty Career Research Training Award

ASTRO funds research in radiation biology, cancer biology and radiation physics. Funding opportunities are available for junior faculty and residents.   The Junior Faculty award is for faculty in early stages of their career to explore opportunities in research.  It provides an opportunity to have focused time for research projects in radiation oncology, biology or physics and provides funds to generate pilot data that can be used for future federal funding applications.
Amount & Project Period: $200,000 - 2 years
Eligibility: Board-eligible physician or physicist in radiation oncology or a radiobiologist w/in first 5 years of junior faculty appt.;
Candidate and at least one mentor must be active ASTRO members;
At least 50% effort required for this award
Link: Overview
 

Residents/Fellows in Radiation Oncology Seed Grant

This grant is designed to support residents or fellows who are planning a career focusing primarily on basic science or clinical research.  Specific areas of interest may include but are not limited to: 1. Basic and clinical research in the radiation therapy sciences. 2. Projects in which innovative techniques, new methods or special equipment leading to better patient care are developed. 3. Aspects of health care planning and delivery, including outcome evaluation studies (i.e., health services research-related activities). 4. Development of programs in health education relevant to the radiation therapy sciences.
Amount & Project Period: $25,000 - 1 year
Eligibility: Candidate and at least one mentor must be active ASTRO members;
At least 75% effort required for this award
Link: Overview


Semi-annual Due Date
April 01 See Below Non-federal Career Development

American Cancer Society
Career Development Awards

The first of 2 annual deadlines for career development awards in a process where scientists propose projects that they believe are ready to be tackled with the available knowledge and techniques.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Links: proposalCENTRAL |  ACS Grant Types
Postdoctoral Fellowships
Amount & Project Period: $48,000, $50,000, and $52,000 per year - 3 years
$4,000/yr. fellowship allowance.
Eligibility: Must be U.S. citizen or permanent resident of U.S. at application.
Mentored Research Scholar Grant
Amount & Project Period: $135,000/yr. (Direct Costs) - 5 years
Eligibility: Be w/in first 4 years of initial full-time faculty position 
Research Scholar Grants
Amount & Project Period: $165,000/yr. (Direct Costs) - 4 years
Eligibility: Must currently have an independent research or faculty position
April 01 All Faculty Ranks Non-federal Palliative Care

Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

To support clinician investigators conducting patient-oriented research in palliative care, applications are solicited for pilot/exploratory research grants in palliative care of cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of competing successfully for larger grants.
Due Dates: Mar. 30 (OSR) Ι Apr. 01 (Sponsor)
Amount & Project Period: $60,000/yr. (Direct Costs) - 1 to 2 years
Eligibility: All Faculty Ranks - Must hold a full-time faculty position or equiv. in U.S.
Contact: Office of Sponsored Research (x6804)
Links: RFA Ι proposalCENTRAL (Submission Site)

NEW
April 01 All Ranks Non-federal Myeloproliferative Neoplasms

The MPN Research Foundation
2017 MPN Challenge
A Grant Program supported by the MPN Research Foundation and the Leukemia & Lymphoma Society  

The objective is to change the trajectory and ultimate prognosis for patients with myeloproliferative neoplasms (MPNs), including MF, PV and ET.  This program represents an important partnership between MPNRF and LLS, who share a mission to advance the scientific understanding of MPNs and bring new treatments and the hope for a cure to patients with these rare diseases.
Due Dates: Mar 30 (OSR) Ι Apr. 01 (via email to Sponsor)
Amount & Project Period: $200,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: 2017 Request for Research Proposals


NEW
April 01 Postdocs Non-federal Career Development

Cancer Research Institute
Irvington Postdoctoral Fellowship Program

 Candidate must be working in areas directly related to cancer immunology.  Eligible projects fall into the broad field of immunology and must show relevance to solving the cancer problem. Proposals that do not encompass both these areas will not be considered.
Due Dates: Mar 30 (OSR) Ι Apr. 01 (Sponsor)
Additional 2017 Due Date:  Oct. 01
Amount & Project Period: 3 years
Annual Stipend:  $55,000, $57,000 & $59,000
Institutional Allowance:  $1,500/yr.
Eligibility: Must have doctoral degree by award activation;
Must have less than 5 years postdoc experience;
Must have less than 3 years' experience in sponsor lab at award activation
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines
UG3/UH3 NCI

NEW
April 09 (LOI) All Ranks Federal Quantitative Imaging

Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment

This FOA seeks applications addressing development, optimization and validation of quantitative imaging (QI) software tools and methods for prediction and/or measurement of response to cancer therapies or for planning and validating radiation therapy treatment strategies in clinical trials.   The initial UG3 exploratory phase is to be used for the development and optimization of QI tools and methods chosen for study by the investigating team, while the UH3 phase is for the clinical validation of the tools/methods developed in the UG3 phase.
Due Dates: Apr. 09 (Letter of Intent)
May 05 (OSR) Ι May 09 (Sponsor)
Additional 2017 Due Date:  September 12th
Amount & Project Period: $300,000/yr. (Direct Costs UG3 phase) - 2 years
$500,000/yr. (Direct Costs UH3 phase) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-128
Companion FOA: PAR-17-129 (U01)
Admin. Supplement NCI

Mechanisms eligible for supplement: R21, R33, U01, & U24

                     NEW

 
April 13 All Ranks Federal Technology Collaborations

Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research

To accelerate the development of new enabling cancer technologies, the NCI invites requests for supplemental funding to support and encourage new multidisciplinary scientific collaborations among awardees from the Innovative Molecular Analysis Technologies (IMAT) program which supports highly innovative, data-generating platforms and methodologies and the Informatics Technologies for Cancer Research (ITCR) program which supports powerful data processing and visualization technologies.
Due Dates: Apr. 10 (OSR)|Apr. 12 (Sponsor)
Additional 2017 Due Dates: Jul. 25th & Dec. 12th
Amount & Project Period: Limited to $50,000/yr. (Direct Costs) per parent award.  Project and budget periods must be w/in currently approved project period for existing parent award.
Eligibility: Individual(s) must hold an active grant or cooperative agreement as noted in left column
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-143


NEW
April 13, 4:00pm, EST All Ranks Non-federal Drug Discovery

Sanford Burnham Prebys Medical Discovery Institute
Florida Translational Research Program

The Program provides Florida-based scientists with access to experienced professionals and state-of-the-art technological resources for drug discovery to facilitate an interdisciplinary, collaborative approach to establish a pipeline of potential new treatments for today's most challenging and unmet medical needs.
Due Dates: Apr. 13, 4:00pm (EST)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: FTRP Projects


NEW
April 14 Postdocs/Early-stage Clinicians Non-federal Career Development

William Guy Forbeck Research Foundation
Scholar Award

Scholars have the unique opportunity to attend the Annual Forbeck Forum, a 3-day retreat in Lake Geneva, Wisconsin for four consecutive years   The Forum topic this year is MYC and RAS.  The key objectives of the Scholar Retreat are:
     Expedite current research
     Bridge the gap between institutions and scientific specializations
     Share issues relating to the career path of a young investigator
Additional benefits of being a Forbeck Scholar include the opportunity to host a Focus Meeting and apply for research funding through the Collaborative Research Program.
Due Dates: Apr. 14 (Submit application to lauren@wgfrf.org or
admin@wgfrf.org)
Amount & Project Period: Scholars will participate in four sequential retreats, with all expenses paid by WGFRF.
Eligibility: Scholars may include post-doctoral fellows and clinicians in the early phases of their career.
Contact: Lauren Roadman, Administrator,  lauren@wgfrf.org
Links: WGFRF Scientific Activities Ι Scholars
R21 NIH
NCI is a participating Institute

NEW
April 23 (LOI) All Ranks Federal Liver

Mechanisms of Disparities in Chronic Liver Diseases and Cancer

The purpose of the initiative is to support multidisciplinary research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US.
Due Dates: Apr. 23 (Letter of Intent)
May 18 (OSR) Ι May 22 (Sponsor)
Additional Due Dates: Apr. 4, 2018, Apr. 4, 2019
Amount & Project Period: $275,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-150
Companion FOA: PAR-17-151 (R01)

NEW
April 24 All Faculty Ranks Non-federal Prostate

Prostate Cancer Foundation
2017 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer

Awards are for investigations of metastatic, lethal prostate cancer. Awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.
Due Dates: Apr. 20 (OSR) Ι Apr. 24 (Sponsor)
Online application submission portal live at https://pcf.smartsimple.com as of  Friday, February 10th)
Amount & Project Period: $1 million per team - 2 years
Eligibility: Team should be composed of at least 3 highly experienced investigators and may be assembled from one or more institutions;
Team must include at least one young investigator as an integral contributor. (Young investigator may be Postdoc, Instructor, Research Associate, Asst. Professor, or equiv. and sh/be w/in 6 years of completing a professional degree or clinical training, and have received <$200,000 in current direct research funding from all sources including institutional funds.)
Contact: Office of Sponsored Research (x6804)
Links: RFA | Challenge Awards
U01 NCI


NEW
April 25 (LOI) All Ranks Federal Screening

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

Applications are encouraged that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers.  Appropriate applications should propose to intervene at one or more levels, and must measure outcomes at three or more levels, while accounting for interactions that occur between levels.
Due Dates: Apr. 25 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Amount & Project Period: It is anticipated and encouraged that requests be in the range of $400,000 to $500,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-146
U01 NCI

NEW
April 27 (LOI) All Ranks  Federal Care Delivery

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

This FOA seeks to advance the science of multilevel interventions in 3 ways: a) by establishing a common conceptualization of levels and associated level-specific factors that affect practice; b) by standardizing metrics of the levels and their main effects on other levels and the individuals needing follow-up care; and c) by developing and standardizing analysis of the effect of interventions on individuals, groups, and organizations responsible for intervention implementation. This FOA also encourages applications that test interventions to improve the follow-up of abnormal screening in one or more ways, including: a) measuring multilevel effects of single-level interventions; b) comparing single vs. multilevel interventions; and c) testing multilevel interventions.
Due Dates: Apr. 27 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Additional Due Date:  Sept.  21st
Amount & Project Period: $450,000 - $500,000/yr. (Direct Costs) Note:  Larger budgets may be requested but no request may exceed $750,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks - Multiple PD/PI applications could have different responsibilities w/respect to one or more of the following: 1) analysis and metrics, 2) medical care interventions, & 3) behavioral interventions.
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-108


NEW
April 30 All Ranks Non-federal Research Projects

Elsa U. Pardee Foundation
Research Grants

The Foundation funds research directed toward identifying new treatments or cures for cancer, and particularly encourages applications  allowing establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.  Project relevance to cancer detection, treatment, or cure should be clearly identified.
Due Dates: Apr. 27 (OSR) Ι Apr. 30 (Sponsor)
Additional 2017 Due Date:  Aug. 31st
Amount & Project Period: No limits stated; must be reasonably & clearly supported by scope of project in application - 1 year suggested
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Application Process
R01 NCI

NEW
April 30 (LOI) All Ranks Federal Imaging

Perception and Cognition Research to Inform Cancer Image Interpretation  

The purpose is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.
Due Dates: Apr. 30 (Letter of Intent)
May 25 (OSR) Ι May 30 (Sponsor)
Additional 2017 Due Date:  September 26th
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact:  Office of Sponsored Research (x6804)
FOA Link: PAR-17-125
Companion FOA: PAR-17-124 (R21)
R01 NIAID

NEW
May 07 All Ranks Federal Natural Killer (NK) Cells

NK Cells to Induce Immunological Memory to Prevent HIV Infection

The purpose is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination.
Due Dates: May 04 (OSR) Ι May 07 (Sponsor)
Additional Due Dates:  Standard Aids Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-114
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org